213 related articles for article (PubMed ID: 34376747)
1. Effects of selective EP2 receptor agonist, omidenepag, on trabecular meshwork cells, Schlemm's canal endothelial cells and ciliary muscle contraction.
Nakamura N; Honjo M; Yamagishi R; Igarashi N; Sakata R; Aihara M
Sci Rep; 2021 Aug; 11(1):16257. PubMed ID: 34376747
[TBL] [Abstract][Full Text] [Related]
2. Effects of topical TGF-β1, TGF-β2, ATX, and LPA on IOP elevation and regulation of the conventional aqueous humor outflow pathway.
Nakamura N; Yamagishi R; Honjo M; Igarashi N; Shimizu S; Aihara M
Mol Vis; 2021; 27():61-77. PubMed ID: 33633440
[TBL] [Abstract][Full Text] [Related]
3. Interaction Between Pilocarpine and Ripasudil on Intraocular Pressure, Pupil Diameter, and the Aqueous-Outflow Pathway.
Yamagishi-Kimura R; Honjo M; Komizo T; Ono T; Yagi A; Lee J; Miyata K; Fujimoto T; Inoue T; Tanihara H; Nishida J; Uchida T; Araki Y; Aihara M
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1844-1854. PubMed ID: 29677344
[TBL] [Abstract][Full Text] [Related]
4. Activation of Prostaglandin FP and EP2 Receptors Differently Modulates Myofibroblast Transition in a Model of Adult Primary Human Trabecular Meshwork Cells.
Kalouche G; Beguier F; Bakria M; Melik-Parsadaniantz S; Leriche C; Debeir T; Rostène W; Baudouin C; Vigé X
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1816-25. PubMed ID: 27082296
[TBL] [Abstract][Full Text] [Related]
5. Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells.
Yamamoto Y; Taniguchi T; Inazumi T; Iwamura R; Yoneda K; Odani-Kawabata N; Matsugi T; Sugimoto Y; Shams NK
J Ocul Pharmacol Ther; 2020 Apr; 36(3):162-169. PubMed ID: 31934812
[No Abstract] [Full Text] [Related]
6. Suberoylanilide hydroxamic acid (SAHA) inhibits transforming growth factor-beta 2-induced increases in aqueous humor outflow resistance.
Fujimoto T; Inoue-Mochita M; Iraha S; Tanihara H; Inoue T
J Biol Chem; 2021 Sep; 297(3):101070. PubMed ID: 34389355
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells.
Suzuki S; Furuhashi M; Tsugeno Y; Umetsu A; Ida Y; Hikage F; Ohguro H; Watanabe M
J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329980
[TBL] [Abstract][Full Text] [Related]
8. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
Rao PV; Deng PF; Kumar J; Epstein DL
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1029-37. PubMed ID: 11274082
[TBL] [Abstract][Full Text] [Related]
9. Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells.
Kaneko Y; Ohta M; Inoue T; Mizuno K; Isobe T; Tanabe S; Tanihara H
Sci Rep; 2016 Jan; 6():19640. PubMed ID: 26782355
[TBL] [Abstract][Full Text] [Related]
10. The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey.
Nilsson SF; Drecoll E; Lütjen-Drecoll E; Toris CB; Krauss AH; Kharlamb A; Nieves A; Guerra T; Woodward DF
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4042-9. PubMed ID: 16936121
[TBL] [Abstract][Full Text] [Related]
11. Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys.
Fuwa M; Toris CB; Fan S; Taniguchi T; Ichikawa M; Odani-Kawabata N; Iwamura R; Yoneda K; Matsugi T; Shams NK; Zhang JZ
J Ocul Pharmacol Ther; 2018 Sep; 34(7):531-537. PubMed ID: 29989843
[TBL] [Abstract][Full Text] [Related]
12. The effects of exosomes derived from trabecular meshwork cells on Schlemm's canal endothelial cells.
Takahashi E; Saruwatari J; Fujimoto T; Tanoue Y; Fukuda T; Inoue T
Sci Rep; 2021 Nov; 11(1):21942. PubMed ID: 34754027
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle.
Krauss AH; Wiederholt M; Sturm A; Woodward DF
Exp Eye Res; 1997 Mar; 64(3):447-53. PubMed ID: 9196397
[TBL] [Abstract][Full Text] [Related]
14. Additive Intraocular Pressure-Lowering Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, Combined with Existing Antiglaucoma Agents in Conscious Ocular Normotensive Monkeys.
Fuwa M; Shimazaki A; Odani-Kawabata N; Kirihara T; Taniguchi T; Iwamura R; Yoneda K; Kato M; Morishima K; Shams NK
J Ocul Pharmacol Ther; 2021 May; 37(4):223-229. PubMed ID: 33600237
[No Abstract] [Full Text] [Related]
15. Addition of EP2 agonists to an FP agonist additively and synergistically modulates adipogenesis and the physical properties of 3D 3T3-L1 sphenoids.
Ida Y; Watanabe M; Umetsu A; Ohguro H; Hikage F
Prostaglandins Leukot Essent Fatty Acids; 2021 Aug; 171():102315. PubMed ID: 34246925
[TBL] [Abstract][Full Text] [Related]
16. Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves' Orbitopathy.
Ida Y; Ichioka H; Furuhashi M; Hikage F; Watanabe M; Umetsu A; Ohguro H
Cells; 2021 Nov; 10(11):. PubMed ID: 34831419
[TBL] [Abstract][Full Text] [Related]
17. The effect of Rho-associated protein kinase inhibitor on monkey Schlemm's canal endothelial cells.
Kameda T; Inoue T; Inatani M; Fujimoto T; Honjo M; Kasaoka N; Inoue-Mochita M; Yoshimura N; Tanihara H
Invest Ophthalmol Vis Sci; 2012 May; 53(6):3092-103. PubMed ID: 22491412
[TBL] [Abstract][Full Text] [Related]
18. S1P₂ receptor regulation of sphingosine-1-phosphate effects on conventional outflow physiology.
Sumida GM; Stamer WD
Am J Physiol Cell Physiol; 2011 May; 300(5):C1164-71. PubMed ID: 21289286
[TBL] [Abstract][Full Text] [Related]
19. Involvement of RhoA/Rho-associated kinase signal transduction pathway in dexamethasone-induced alterations in aqueous outflow.
Fujimoto T; Inoue T; Kameda T; Kasaoka N; Inoue-Mochita M; Tsuboi N; Tanihara H
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7097-108. PubMed ID: 22969074
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study).
Aihara M; Lu F; Kawata H; Tanaka Y; Yamamura K; Odani-Kawabata N; Shams NK
J Ocul Pharmacol Ther; 2019 Dec; 35(10):542-550. PubMed ID: 31674861
[No Abstract] [Full Text] [Related]
[Next] [New Search]
